300 related articles for article (PubMed ID: 16837890)
1. First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055.
Raus K; Brucker C; Gorkow C; Wuttke W
Menopause; 2006; 13(4):678-91. PubMed ID: 16837890
[TBL] [Abstract][Full Text] [Related]
2. Effects of black cohosh extract on body weight gain, intra-abdominal fat accumulation, plasma lipids and glucose tolerance in ovariectomized Sprague-Dawley rats.
Rachoń D; Vortherms T; Seidlová-Wuttke D; Wuttke W
Maturitas; 2008; 60(3-4):209-15. PubMed ID: 18691839
[TBL] [Abstract][Full Text] [Related]
3. The non-estrogenic alternative for the treatment of climacteric complaints: Black cohosh (Cimicifuga or Actaea racemosa).
Wuttke W; Jarry H; Haunschild J; Stecher G; Schuh M; Seidlova-Wuttke D
J Steroid Biochem Mol Biol; 2014 Jan; 139():302-10. PubMed ID: 23459142
[TBL] [Abstract][Full Text] [Related]
4. An isopropanolic extract of black cohosh does not increase mammographic breast density or breast cell proliferation in postmenopausal women.
Hirschberg AL; Edlund M; Svane G; Azavedo E; Skoog L; von Schoultz B
Menopause; 2007; 14(1):89-96. PubMed ID: 17019374
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms.
Osmers R; Friede M; Liske E; Schnitker J; Freudenstein J; Henneicke-von Zepelin HH
Obstet Gynecol; 2005 May; 105(5 Pt 1):1074-83. PubMed ID: 15863547
[TBL] [Abstract][Full Text] [Related]
6. Effects of black cohosh (Cimicifuga racemosa) on bone turnover, vaginal mucosa, and various blood parameters in postmenopausal women: a double-blind, placebo-controlled, and conjugated estrogens-controlled study.
Wuttke W; Gorkow C; Seidlová-Wuttke D
Menopause; 2006; 13(2):185-96. PubMed ID: 16645532
[TBL] [Abstract][Full Text] [Related]
7. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers.
Wuttke W; Seidlová-Wuttke D; Gorkow C
Maturitas; 2003 Mar; 44 Suppl 1():S67-77. PubMed ID: 12609561
[TBL] [Abstract][Full Text] [Related]
8. The Cimicifuga racemosa special extract BNO 1055 prevents hot flashes in ovariectomized rats.
Kapur P; Wuttke W; Seidlova-Wuttke D
Phytomedicine; 2010 Sep; 17(11):890-4. PubMed ID: 20696560
[TBL] [Abstract][Full Text] [Related]
9. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial.
Frei-Kleiner S; Schaffner W; Rahlfs VW; Bodmer Ch; Birkhäuser M
Maturitas; 2005 Aug; 51(4):397-404. PubMed ID: 16039414
[TBL] [Abstract][Full Text] [Related]
10. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
Samsioe G; Dvorak V; Genazzani AR; Hamann B; Heikkinen J; Mueck AO; Suzin J; Kawakami FT; Ferreira A; Sun D; Arguinzoniz M
Maturitas; 2007 Jun; 57(2):171-81. PubMed ID: 17317046
[TBL] [Abstract][Full Text] [Related]
11. Lack of promotion of estrogen-dependent mammary gland tumors in vivo by an isopropanolic Cimicifuga racemosa extract.
Freudenstein J; Dasenbrock C; Nisslein T
Cancer Res; 2002 Jun; 62(12):3448-52. PubMed ID: 12067987
[TBL] [Abstract][Full Text] [Related]
12. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K
Menopause; 2008; 15(1):51-8. PubMed ID: 18257142
[TBL] [Abstract][Full Text] [Related]
13. Effects of black cohosh (Cimicifuga racemosa) and estrogen on metaphyseal fracture healing in the early stage of osteoporosis in ovariectomized rats.
Kolios L; Schumann J; Sehmisch S; Rack T; Tezval M; Seidlova-Wuttke D; Frosch KH; Stuermer KM; Stuermer EK
Planta Med; 2010 Jun; 76(9):850-7. PubMed ID: 20104444
[TBL] [Abstract][Full Text] [Related]
14. Long-term endometrial and breast safety of a specific, standardized soy extract.
Palacios S; Pornel B; Vázquez F; Aubert L; Chantre P; Marès P
Climacteric; 2010 Aug; 13(4):368-75. PubMed ID: 20380569
[TBL] [Abstract][Full Text] [Related]
15. Phytoestrogens: endocrine disrupters or replacement for hormone replacement therapy?
Wuttke W; Jarry H; Becker T; Schultens A; Christoffel V; Gorkow C; Seidlová-Wuttke D
Maturitas; 2003 Mar; 44 Suppl 1():S9-20. PubMed ID: 12609555
[TBL] [Abstract][Full Text] [Related]
16. Black cohosh: efficacy, safety, and use in clinical and preclinical applications.
McKenna DJ; Jones K; Humphrey S; Hughes K
Altern Ther Health Med; 2001; 7(3):93-100. PubMed ID: 11347288
[TBL] [Abstract][Full Text] [Related]
17. Endometrial safety assessment of a specific and standardized soy extract according to international guidelines.
Palacios S; Pornel B; Bergeron C; Chantre P; Nogales F; Aubert L; Vazquez F; Eden J; Mares P
Menopause; 2007; 14(6):1006-11. PubMed ID: 17603393
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy and safety of remifemin compared to tibolone for controlling of perimenopausal symptoms].
Bai WP; Wang SY; Liu JL; Geng L; Hu LN; Zhang ZL; Chen SL; Zheng SR
Zhonghua Fu Chan Ke Za Zhi; 2009 Aug; 44(8):597-600. PubMed ID: 20003788
[TBL] [Abstract][Full Text] [Related]
19. Black cohosh with or without St. John's wort for symptom-specific climacteric treatment--results of a large-scale, controlled, observational study.
Briese V; Stammwitz U; Friede M; Henneicke-von Zepelin HH
Maturitas; 2007 Aug; 57(4):405-14. PubMed ID: 17590291
[TBL] [Abstract][Full Text] [Related]
20. Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women.
Manonai J; Chittacharoen A; Udomsubpayakul U; Theppisai H; Theppisai U
Menopause; 2008; 15(3):530-5. PubMed ID: 18202589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
